Acid-Base Disorders

Acid-Base Disorders

Up next

Eye Infections

Send a textNinja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob walk you through a systematic, case-based approach to eye infections that show up everywhere, on exams, in urgent care, and in the middle of the night in the ED. Red eyes, swollen lids, scary diagnoses ...  Show more

CNS Infections

Send a textNinja Nerds!In this episode, Rob and Zach dive into CNS infections and walk through how to build a simple framework to separate and identify meningitis, encephalitis, and brain abscess, then link each one to its classic clinical clues, imaging findings, CSF patterns, a ...  Show more

Recommended Episodes

Episode 116: AML Series, Pt. 2 - MDS/AML Diagnosis and Risk Stratification
The Fellow on Call: The Heme/Onc Podcast

In this week’s episode, we discuss the diagnostic criteria and risk stratification for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), building on our discussion from last week. Also, if you have not done so, please do check out our hemepath series to ensure y ...

  Show more

Episode 079: Heme Consult Series: When anticoagulation fails, Part 1
The Fellow on Call: The Heme/Onc Podcast

It’s time for another Heme Consult series, this time focusing on another common question we see in the hospital and in clinic: “is this anticoagulation failure?”

In this two-part series, we bre ...

  Show more

Episode 072: Introduction to Diffuse Large B-Cell Lymphoma (DLBCL)
The Fellow on Call: The Heme/Onc Podcast

This week, we kick off a new series focusing on diffuse large B-cell lymphoma. In this first episode, we discuss the basics that everyone needs to understand before diving into the management of this disease.

<p class="" style="white- ...  Show more

Episode 125: AML Series, Pt 11 - Treatment of patients unfit for intensive therapy
The Fellow on Call: The Heme/Onc Podcast

In today’s episode, we discuss how to approach AML treatment for patients who are unfit for intensive therapy.

Episode contents:

- How do we assess ...

  Show more